List of works - Aranzazu Manzano

A Transcriptomic Immunologic Signature Predicts Favorable Outcome in Neoadjuvant Chemotherapy Treated Triple Negative Breast Tumors

scientific article published on 18 December 2019

A nomogram for predicting complications in patients with solid tumours and seemingly stable febrile neutropenia

scientific article published on 17 May 2016

A snapshot of COVID-19 infection in patients with solid tumors

scientific article published on 03 December 2020

Adherence to the Sociedad Española de Oncología Médica (SEOM) Algorithm for the Treatment of Hyponatremia in Oncology Patients in Spain: The ALGA Study

scientific article published on 27 October 2020

Cervical carcinomas that overexpress human trophoblast cell-surface marker (Trop-2) are highly sensitive to the antibody-drug conjugate sacituzumab govitecan

scientific article published on 22 January 2020

Chemotherapy-induced response of liver hemangiomas in a patient with a germ cell tumor: a case report.

scientific article published on 9 February 2018

Clinicopathological and Molecular Characterization of Metastatic Gastrointestinal Stromal Tumors with Prolonged Benefit to Frontline Imatinib

scientific article published on 20 August 2018

Colorectal cancer chemoprevention: is this the future of colorectal cancer prevention?

scientific article

Efficacy and safety results from GEICO 1205, a randomized phase II trial of neoadjuvant chemotherapy with or without bevacizumab for advanced epithelial ovarian cancer

scientific article published on 01 July 2019

Genomic Mapping Identifies Mutations in RYR2 and AHNAK as Associated with Favorable Outcome in Basal-Like Breast Tumors Expressing PD1/PD-L1

scientific article published on 11 August 2020

Genomic Signatures of Immune Activation Predict Outcome in Advanced Stages of Ovarian Cancer and Basal-Like Breast Tumors

scientific article published on 01 January 2019

High risk of thrombosis in patients with advanced lung cancer harboring rearrangements in ROS1

scientific article published on 06 November 2020

Incidence, predictors and prognostic significance of thromboembolic disease in patients with advanced ALK-rearranged non-small cell lung cancer

scientific article published on 03 May 2018

Inhibition of BET Bromodomain Proteins with GS-5829 and GS-626510 in Uterine Serous Carcinoma, a Biologically Aggressive Variant of Endometrial Cancer

scientific article published on 25 June 2018

In vitro and in vivo activity of sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (Trop-2) in uterine serous carcinoma

scientific article published on 12 December 2019

Management of gynecological cancer in pregnant patients

scientific article published on 11 October 2018

Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors

scientific article published on 24 December 2018

Novel targeted therapies in ovarian and uterine carcinosarcomas

scientific article published on 01 June 2018

PARP-1 activity (PAR) determines the sensitivity of cervical cancer to olaparib

scientific article published on 18 August 2019

PI3K oncogenic mutations mediate resistance to afatinib in HER2/neu overexpressing gynecological cancers

scientific article published on 07 January 2019

PI3K-Akt signaling controls PFKFB3 expression during human T-lymphocyte activation.

scientific article published on 12 February 2018

Patterns of care and outcome for patients with glioblastoma diagnosed during 2008-2010 in Spain ⬇️

scientific article published on March 3, 2013

Preclinical Activity of Sacituzumab Govitecan, an Antibody-Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) Linked to the Active Metabolite of Irinotecan (SN-38), in Ovarian Cancer

scientific article published on 12 February 2020

Preclinical activity of sacituzumab govitecan (IMMU-132) in uterine and ovarian carcinosarcomas

scientific article published on 04 February 2020

Prediction of serious complications in patients with seemingly stable febrile neutropenia: validation of the Clinical Index of Stable Febrile Neutropenia in a prospective cohort of patients from the FINITE study

scientific article published on 5 January 2015

Renal cell cancer metastases to esophagus and stomach successfully treated with radiotherapy and pazopanib

scientific article published in January 2015

Sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2, shows cytotoxic activity against poorly differentiated endometrial adenocarcinomas in vitro and in vivo

scientific article published on 14 January 2020

Sorafenib for non-selected patient population with advanced hepatocellular carcinoma: efficacy and safety data according to liver function